Inhibition of Lung Adenocarcinoma Growth by using Oridonin
MedScien · 2023
DOI: 10.61173/0f01c260 ↗Kurz gefasst
Fachartikel in der Zeitschrift MedScien, 2023. Verfasst von Zhongrui Jiang. Die Arbeit nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The abnormal activity of the Notch signal pathway is a common manifestation of many cancerous cells. Therefore,blocking the notch pathway of cancer cells positively affects cancer treatment. Because oridonin directly acts on thetarget notch receptor 1-4 cancer cells, inhibiting the Notch signaling pathway can inhibit the growth of cancer cells.
Zitieren
APA
Jiang, Z. (2023). Inhibition of Lung Adenocarcinoma Growth by using Oridonin. MedScien. https://doi.org/10.61173/0f01c260
Vancouver
Jiang Z. Inhibition of Lung Adenocarcinoma Growth by using Oridonin. MedScien. 2023. doi:10.61173/0f01c260
BibTeX
@article{Jiang2023,
author = {Jiang, Zhongrui},
title = {Inhibition of Lung Adenocarcinoma Growth by using Oridonin},
journal = {MedScien},
year = {2023},
doi = {10.61173/0f01c260}
}
EUVIMED